LCN2 and cancer: Expression of LCN2 is also associated with epithelial-mesenchymal transition (EMT), invasion, progression and metastatic spread of many types of cancer cells including those of breast, cholangiocellular, intestinal or prostate origin but model-specific differences exist (179–183).